Aditxt, Beyond Air Surge Pre-Market; Elicio Therapeutics Dips on June 18, 2026

Aditxt Inc. (ADTX) and Beyond Air Inc. (BYAH) shares posted significant gains in pre-market trading on June 18, 2026, while Elicio Therapeutics (ELTX) experienced a notable decline. The movements followed distinct corporate announcements impacting investor sentiment ahead of market open. ADTX surged 18% to $0.75 after the company reported positive interim clinical data for its AditxtScore™ diagnostic platform. Concurrently, BYAH climbed 25% to $2.10, driven by an announcement of new regulatory clearance for its LungFit® GO nitric oxide generator, expanding its market reach. Conversely, ELTX shares fell 12% to $1.30 following news of a delay in its lead oncology candidate's Phase 2 clinical trial due to unexpected patient enrollment challenges. The company stated it is reassessing its timeline for trial completion and data readout.